-- 百威亞太釀酒公司(HKG:1876)公佈,儘管銷量略有增長,但由於營收下滑,第一季歸屬於股東的利潤略有下降。 根據週二提交給香港交易所的文件,這家啤酒公司公佈截至3月31日的三個月內,歸屬於股東的利潤為2.26億美元,去年同期為2.34億美元。 每股盈餘從去年同期的1.76美元降至1.68美元,但遠高於Visible Alpha先前預測的0.02美元。 營收下降0.7%至14.9億美元,高於Visible Alpha先前預測的14.4億美元;由於在中國的投資增加,每百升營收下降0.8%。 傑富瑞分析師表示,銷售額比預期高出3%,這得益於東西方市場的共同成長,其中印度市場的強勁表現尤其突出。 在印度,銷售和收入均實現了強勁的兩位數成長,這得益於其產品組合持續的高端化策略。 在中國,銷售量下降了1.5%,但降幅有所收窄;收入下降了4%,原因是通路和品牌推廣投入增加。 在中國增加的投資主要用於支持批發商、拓展入戶管道和線上和線下整合(O2O)管道,以及加強品牌和行銷活動。 這包括加大行銷投入,例如在全國推廣百威夢龍啤酒,並與埃爾林·哈蘭德以及FIFA世界盃平台合作。 在韓國,銷量下降了兩位數左右,而收入則在高基數下下降了個位數,這反映出公司正在為2025年4月漲價做準備。 此外,該公司還指出其韓國子公司東方啤酒廠(Oriental Brewery)正面臨持續的法律和稅務問題。該公司已累積8,600萬美元的特殊費用,這些費用與海關審計相關的索賠有關,該公司正在對此提出異議。 2025年,該事件升級,該公司因涉嫌挪用公款、商業賄賂以及與麥芽進口相關的關稅問題而被起訴。 多家實體和高階主管也被列為共同被告,訴訟仍在進行中。 該子公司還收到了韓國當局先前年度的約7,100萬美元的稅款評估,並已預付約6,200萬美元,同時正在對部分索賠提出異議。 傑富瑞分析師在致客戶的報告中指出:“我們認為投資者將關注以下幾點:1)中國市場戰略;2)原材料成本趨勢和利潤率前景;3)亞太東部地區在行業疲軟背景下提價的可能性;以及4)印度市場潛力。” 週二早盤交易中,百威亞太區股價小幅上漲。
Related Articles
Smartgroup Welcomes Australian Government Decision to Maintain Electric Car Discount for a Year, Shares Reach Two-Year Peak
Smartgroup (ASX:SIQ) welcomes a decision by the Australian government to maintain the electric car discount for another year, according to a Tuesday statement.It noted that the policy provides certainty for the charging industry, supporting further investment in Australia's charging infrastructure and helping build the network needed for broader electric vehicle adoption.Its shares jumped 7% in recent trading, reaching a two-year peak.
Market Chatter: Qantas CEO Becoming 'More Optimistic' on Fuel Supply
Qantas Airways (ASX:QAN) Chief Executive Vanessa Hudson said the company is becoming "more optimistic" on fuel supply, Bloomberg News reported Tuesday.Speaking at the Macquarie Australia Conference, Hudson said the company has fuel commitments up to the middle of June, per the report.Hudson noted that the airline registered strong demand for domestic and international air travel despite high fuel prices.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Sigma Healthcare Says Chemist Warehouse Brand to Enter UK Under Agreement With Pharmacy Group; Shares Rise 4%
Sigma Healthcare (ASX:SIG) said Tuesday signed a memorandum of understanding with Greenlight Healthcare, under which the Chemist Warehouse brand will enter the UK market.The company said in a statement that it will acquire a 75% interest in a number of stores of the employee-owned pharmacy group, with 25% continuing to be held by GreenLight.Sigma will license the Chemist Warehouse brand and intellectual property, and provide retail support, while GreenLight will provide the dispensary and professional services requirements as well as back office support.The first phase of the joint venture will focus on rebranding and developing up to five stores initially, with the first site to be in Hoxton Street, northeast of the city of London. If the first phase proves to be successful, more stores could be developed in the second phase. The parties plan to identify existing GreenLight pharmacies and where appropriate develop or relocate these into Chemist Warehouse stores.Sigma Healthcare's shares rose nearly 4% in recent trading on Tuesday.